These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27268228)

  • 1. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics.
    Garg NK; Singh B; Jain A; Nirbhavane P; Sharma R; Tyagi RK; Kushwah V; Jain S; Katare OP
    Colloids Surf B Biointerfaces; 2016 Oct; 146():114-26. PubMed ID: 27268228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ligand (s) anchored lipobrid nanoconstruct mediated delivery of methotrexate: an effective approach in breast cancer therapeutics.
    Garg NK; Singh B; Kushwah V; Tyagi RK; Sharma R; Jain S; Katare OP
    Nanomedicine; 2016 Oct; 12(7):2043-2060. PubMed ID: 27234306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
    Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
    Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
    Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
    Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution.
    Battaglia L; Serpe L; Muntoni E; Zara G; Trotta M; Gallarate M
    Nanomedicine (Lond); 2011 Nov; 6(9):1561-73. PubMed ID: 22011315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
    Vakilinezhad MA; Amini A; Dara T; Alipour S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and TPGS based novel core-shell type nanocapsular sustained release system of methotrexate for intravenous application.
    Katiyar SS; Kushwah V; Dora CP; Jain S
    Colloids Surf B Biointerfaces; 2019 Feb; 174():501-510. PubMed ID: 30497012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and functional attributes of lipidic nanoconstructs of lycopene: An innovative endeavour for enhanced cytotoxicity in MCF-7 breast cancer cells.
    Jain A; Sharma G; Kushwah V; Thakur K; Ghoshal G; Singh B; Jain S; Shivhare US; Katare OP
    Colloids Surf B Biointerfaces; 2017 Apr; 152():482-491. PubMed ID: 28196351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma.
    Ruckmani K; Sivakumar M; Ganeshkumar PA
    J Nanosci Nanotechnol; 2006; 6(9-10):2991-5. PubMed ID: 17048509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.
    Wang J; Zhang Z; Ai Y; Liu F; Chen MM; Liu D
    Carbohydr Res; 2021 Mar; 501():108275. PubMed ID: 33657498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
    Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
    Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
    Ferreira M; Chaves LL; Lima SA; Reis S
    Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
    Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
    J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F; Li L; Liu B; Chen Z; Li C
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
    Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
    Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.